AMR surveillance

Antimicrobial resistance


This data set describes antimicrobial resistance (AMR) data from the WHO European Region gathered through the Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Centre for Disease Prevention and Control (ECDC) European Antimicrobial Resistance Surveillance Network (EARS-Net). The data set aims to create awareness about antibiotic resistance situation and advocate AMR control policies in participating countries. Data is available for 19 countries and Kosovo (in accordance with United Nations Security Council resolution 1244 (1999)) within CAESAR, and 30 countries within EARS-Net; with remaining WHO European Region Member States marked as “Did not participate in survey” in the dataset.

CAESAR-specific questions not applicable to EARS-Net countries are also marked as “Did not participate in survey”.

Those countries that did not respond to a specific question are marked as "No response" for that question only. Data has been collected by the Control of Antimicrobial Resistance Programme at the Division of Health Emergencies and Communicable Diseases, World Health Organization Regional Office for Europe and the ECDC EARS-Net. Current data is available for multiple years for CAESAR and EARS-Net, and future data collection is foreseen.

CAESAR: Data was collected from the national AMR focal points. Data was published in the Central Asian and Eastern European Surveillance of Antimicrobial Resistance annual reports available online in English and Russian http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/surveillance/central-asian-and-eastern-european-surveillance-of-antimicrobial-resistance-caesar

EARS-Net: European Centre for Disease Prevention and Control. Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC Surveillance Atlas of Infectious Diseases
https://ecdc.europa.eu/en/surveillance-atlas-infectious-diseases

Geographical coverage
CAESAR countries and areas: Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Georgia, Kazakhstan, Kyrgyzstan, Montenegro, Republic of Moldova, Russian Federation, Serbia, Switzerland, Tajikistan, The former Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Ukraine, Uzbekistan and Kosovo (in accordance with United Nations Security Council resolution 1244(1999)).

EARS-Net countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom.

Data quality
Level B data provides an indication of the resistance patterns present in clinical settings in the country, but the proportion of resistance should be interpreted with care. Improvements are needed to attain a more valid assessment of the magnitude and trends of AMR in the country. Levels of evidence are only provided for CAESAR countries and areas.